Cornerstone Therapeutics, Inc. (CRTX) Misses Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Financial Fact:
Research and development: 594K
Today's EPS Names:
CHA, EDXC, YAYO, More
Financial Fact:
Research and development: 594K
Today's EPS Names:
CHA, EDXC, YAYO, More
Join SI Premium – FREE
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q1 EPS of $0.05, $0.05 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20 million.
(NOTE - only 1 analyst covers this stock)
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
(NOTE - only 1 analyst covers this stock)
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- NewtekOne cuts EPS guidance, shifts focus to net interest income
- Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
